Medicine Track and Trace System Approved to Combat Fake Drugs Across Pakistan
The federal cabinet has approved the Medicine Track System for implementation across Pakistan. The initiative aims to eliminate counterfeit and substandard medicines from the market. Therefore, authorities expect stronger protection for patients and greater transparency in the pharmaceutical sector. Federal Health Minister Syed Mustafa Kamal announced the decision after the cabinet approved amendments to the Drug Labelling and Packing Rules, 1978. These amendments will support the launch of a modern digital monitoring framework. In addition, the new system will help regulators monitor medicines more effectively at every stage of distribution. Officials believe the initiative will improve public trust and strengthen the country’s healthcare system. They also expect it to reduce the risks associated with fake medicines.
Digital Tracking to Strengthen Medicine Safety
Syed Mustafa Kamal described the project as a major milestone for public health. He said the government will digitally track and verify every medicine from production to sale. As a result, authorities will find it easier to identify and remove counterfeit medicines from circulation. The new framework will also improve accountability throughout the pharmaceutical supply chain.
Under the regulations, pharmaceutical manufacturers and importers must print standardized two-dimensional (2D) barcodes on medicine packaging. They must also include serialization data for digital verification. Furthermore, consumers will gain access to important product details through authentication tools. For example, they will be able to check expiry dates, pricing information, and product authenticity before making a purchase. These measures will help consumers make safer choices and avoid fraudulent products.
DRAP to Lead Nationwide Implementation
The Drug Regulatory Authority of Pakistan (DRAP) will oversee the implementation of the system. The authority will also issue technical guidelines to help pharmaceutical companies meet compliance requirements. Consequently, manufacturers and importers will receive clear instructions for adopting the new technology.
The health minister said the initiative will improve security and transparency across Pakistan’s pharmaceutical sector. Moreover, it will align local practices with international standards. He added that advanced digital technologies will modernize medicine monitoring and increase consumer confidence. Meanwhile, the government has already consulted industry stakeholders to ensure a smooth rollout. Officials expect the system to create a strong barrier against counterfeit medicines and provide better public health protection nationwide.
